Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Sep. 30, 2020
Current assets:    
Cash $ 5,560,816 $ 959,309
Inventory 828,220 967,993
Prepaid expenses and other current assets 453,376 215,673
Total current assets 6,842,412 2,142,975
Long-term assets:    
Property and equipment, net 6,838 4,552
Other assets 3,500 3,500
Total long-term assets 10,338 8,052
Total assets 6,852,750 2,151,027
Current liabilities:    
Accounts payable 558,833 342,050
Accrued expenses and other liabilities 171,542 248,968
Current portion of derivative liability 1,000,000 0
Current portion of PPP Loan 116,772 37,442
Total current liabilities 1,847,147 628,460
Long-term liabilities:    
Long-term portion of PPP loan 59,528 138,858
Derivative liability 1,207,475 2,316,419
Total long-term liabilities 2,953,921 3,023,058
Total liabilities 4,801,068 3,651,518
Commitments and contingencies
Stockholders' equity (deficit):    
Common stock, $0.001 par value, 800,000,000 shares authorized as of March 31, 2021 and September 30, 2020, 236,719,770 and 193,044,766 shares issued and outstanding as of March 31, 2021 and September 30, 2020 236,720 193,045
Additional paid-in capital 48,316,799 41,862,901
Accumulated deficit (46,501,837) (43,556,437)
Total stockholders' equity (deficit) 2,051,682 (1,500,491)
Total liabilities and stockholders' equity (deficit) 6,852,750 2,151,027
Series 1 convertible notes    
Long-term liabilities:    
Convertible Notes Payable, Noncurrent 550,000 550,000
Series 2 convertible notes    
Long-term liabilities:    
Convertible Notes Payable, Noncurrent 1,050,000 0
Accrued interest $ 86,918 $ 17,781